Author Publication | Study type | Implant groups | Number of patients, n | Implant number, n | Implant length, mm | Implant system | Failed implant, n |
---|---|---|---|---|---|---|---|
Shi et al. 2021 | RCT | Short implants + OSFE | 62 | 62 | 8 | Straumann implants | 1 |
Standard implants + OSFE | 70 | 70 | 10 | 0 | |||
Cannizzaro et al. 2013 | RCT | Short implants + OSFE | 20 | 38 | 8 | Tapered Screw-Vent MP-1 HA Dual Transition Selective Surface | 10 |
Long implants + LSFE | 20 | 44 | 10,13 or 16 | 5 | |||
Yu et al. 2016 | RCT | Short implants + OSFE | 20 | 38 | 6.5 | Thommen dental implants | 0 |
Standard implants + LSFE | 18 | 42 | 11 or 12.5 | 1 |
Author Publication | Implant groups | Survival rate (%) | MBL, mm | Intra-surgical complication, n | Post-surgical complication, n | RBH, mm | Follow-up, y |
---|---|---|---|---|---|---|---|
Shi et al. 2021 | Short implants + OSFE | 98.4 | 0.50 ± 0.30 | 7 sinus membrane perforation | 21 peri-implant mucositis, 2 peri-implantitis | ≥ 6, < 8 | 3 |
Standard implants + OSFE | 100 | 0.53 ± 0.28 | 6 sinus membrane perforation | 13 peri-implant mucositis, 1 peri-implantitis | |||
Cannizzaro et al. 2013 | Short implants + OSFE | 97.4 | 0.41 ± 0.42 | 0 | 1 peri-implant bone loss, 1 peri-implantitis | 3–6 | 5 |
Long implants + LSFE | 88.6 | 0.72 ± 0.41 | 2 sinus membrane perforation | 1 abscess and 1 sinusitis, 1 peri-implant mucositis | |||
Yu et al. 2016 | Short implants + OSFE | 100 | 0.35 ± 0.60 | 2 sinus membrane perforation | 4 nasal bleeding with postoperative headache | 4–5 | 2 |
Standard implants + LSFE | 97.6 | 0.40 ± 0.71 | 1 sinus membrane perforation | 1 abscess, 5 nasal bleeding |